| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6a6f422b091ba12ea61d4adbf1b0e8e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
| filingDate |
2019-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_120030fa77a0de53922ac0e53543ccb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cb5f410d4d1addd81837480292b6955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bae44b50141a7bb870a19eb5ae20140
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5711a53fb03a11aebbc984d7b57b84e1 |
| publicationDate |
2020-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110693863-A |
| titleOfInvention |
Application of pharmaceutical composition in preparation of medicine for treating acute myeloid leukemia |
| abstract |
The invention provides application of a pharmaceutical composition in preparing a medicament for treating acute myelogenous leukemia. The composition consists of a compound R162 (2-allyl-1-hydroxy-9, 10-anthraquinone) and cytarabine, wherein the dosage molar ratio of the cytarabine to the compound R162 is as follows: 1:0.8-1:10. The composition provided by the invention can improve the proliferation inhibiting capability of AML cells. The invention provides a theoretical basis for searching a new treatment method for acute myeloid leukemia. |
| priorityDate |
2019-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |